|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$107,746
|
N/A
|
National Institutes of Health
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$529,634
|
$26,482
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Agricultural Health Study - BioMarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 - 10527
|
$1,102,766
|
$110,277
|
Alavanja, Michael
|
DCEG (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S1
|
$74,856
|
$1,497
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S2
|
$122,401
|
$2,448
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S3
|
$150,000
|
$3,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
$88,423
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Host RNA Processing Factors: Friend or Foe of Oncogenic Retroelements
|
5F30CA165774-03
|
$47,676
|
$47,676
|
BANN, DARRIN
|
PENNSYLVANIA STATE UNIVERSITY
|
|
Corn Farming Study
|
ZIA CP010119 - 02075
|
$1,467
|
$73
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Risk factors for thyroid cancer in the NCI cohorts
|
ZIA CP010219 - 10447
|
$77,072
|
$77,072
|
Berrington, Amy
|
DCEG (NCI)
|
|
Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests
|
5U01CA137026-05
|
$453,162
|
$45,316
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S1
|
$75,000
|
$6,750
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S2
|
$125,000
|
$11,250
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S3
|
$135,233
|
$12,171
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S4
|
$149,838
|
$13,485
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-38
|
$4,444,835
|
$400,035
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$519,474
|
$415,579
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
RhoB in cancer pathogenesis and as a target in combinatorial therapy
|
5R01CA136665-05
|
$303,033
|
$303,033
|
COPLAND, JOHN
|
MAYO CLINIC JACKSONVILLE
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-28S1
|
$48,718
|
$487
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-28
|
$1,485,000
|
$14,850
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,704,173
|
$735,209
|
Custer, Mary
|
CCR (NCI)
|
|
Predictive MRI metrics for tumor aggressiveness in micropapillary thyroid cancer
|
1R21CA176660-01A1
|
$368,728
|
$368,728
|
DAVE, AMITA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
3P30CA047904-26S1
|
$110,216
|
$2,204
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-26S2
|
$72,734
|
$1,455
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA047904-26
|
$4,985,360
|
$99,707
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Genetic analysis of the P13K/Akt pathway in thyroid benign and malignant disease
|
3R01CA128943-05S1
|
$102,705
|
$102,705
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
5R01CA167839-02
|
$336,129
|
$336,129
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Mayo Comprehensive Cancer Center Grant
|
2P30CA015083-40
|
$5,569,750
|
$55,698
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-40S1
|
$43,750
|
$438
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Breast and other cancers following x-rays for scoliosis
|
ZIA CP010222 - 04150
|
$22,378
|
$224
|
Doody, Michele
|
DCEG (NCI)
|
|
SPORE in Thyroid Cancer
|
1P50CA172012-01A1
|
$2,008,466
|
$2,008,466
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Molecular Pathophysiology of Thyroid Cell Growth
|
5R01CA050706-24
|
$379,852
|
$379,852
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling
|
5R01CA173592-02
|
$402,117
|
$402,117
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Advanced Ultrasonic Evaluation of Sentinel Lymph Nodes
|
5R01CA100183-08
|
$234,401
|
$46,880
|
FELEPPA, ERNEST
|
RIVERSIDE RESEARCH INSTITUTE
|
|
Two-Photon Fluorescence Lifetime Microscopy for Breast and Thyroid Cancer Margin
|
1F32CA183400-01
|
$51,530
|
$25,765
|
GIACOMELLI, MICHAEL
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
OSU as Network Lead Academic Participating Site for the NCI NCTN
|
1U10CA180850-01
|
$1,455,849
|
$36,396
|
GOLDBERG, RICHARD
|
OHIO STATE UNIVERSITY
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$2,250
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$4,455
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$107,557
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,436,451
|
$221,823
|
Gulley, James
|
CCR (NCI)
|
|
The NFkB-dependent Secretome and Invasion/Angiogenesis in Thyroid Cancer
|
5R01CA155512-04
|
$300,185
|
$300,185
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
|
5R01CA175994-02
|
$311,725
|
$311,725
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Variation in Radioactive Iodine Use in Treatment of Thyroid Cancer
|
5K07CA154595-04
|
$167,096
|
$167,096
|
HAYMART, MEGAN
|
UNIVERSITY OF MICHIGAN
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$42,233
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Yale Cancer Center NCTN
|
1U10CA180826-01
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Childhood cancer survivor study (CCSS)
|
ZIA CP010131 - 04033
|
$89,625
|
$8,963
|
Inskip, Peter
|
DCEG (NCI)
|
|
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
|
5R01CA178007-02
|
$341,162
|
$341,162
|
JIN, MOONSOO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Genomic and genetic studies of endocrine cancers
|
ZIA BC 011275
|
$829,616
|
$414,808
|
Kebebew, Electron
|
CCR (NCI)
|
|
Therapeutic targets and novel anticancer agents for endocrine cancers
|
ZIA BC 011286
|
$829,616
|
$414,808
|
Kebebew, Electron
|
CCR (NCI)
|
|
Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC)
|
ZIA BC 011287
|
$221,231
|
$221,231
|
Kebebew, Electron
|
CCR (NCI)
|
Total relevant funding to Thyroid for this search: $23,070,505
|